Moneycontrol PRO
HomeNewsBusinessMarketsHot Stocks | Here's why you should bet on TCS, Dr Lal PathLabs, Max Healthcare Institute for short term

Hot Stocks | Here's why you should bet on TCS, Dr Lal PathLabs, Max Healthcare Institute for short term

Shitij Gandhi of SMC Global Securities expects markets to remain under pressure in upcoming sessions as well and likely to trade on volatile path.

December 01, 2021 / 07:25 IST
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Shitij Gandhi, Senior Technical Analyst, SMC Global Securities

    The Indian markets once again witnessed heavy selling on Tuesday as the Nifty slipped below the 17,000 mark with bears reigning on Dalal Street. Banking, auto and metal counters remained laggard while pharma and FMCG, along with IT, supported markets regain to some extent.

    From the derivatives front, Call writers added hefty open interest at 17,200, 17,300 and 17,500 strikes, while Put writers added marginal open interest at 17,000 and 16,800 strikes.

    We expect the markets to remain under pressure in the upcoming sessions as well and to tread on a volatile path. The bulls look a bit uncomfortable at the current juncture as the Nifty has managed to close below its 100-day exponential moving average on daily charts.

    As far as Bank Nifty is concerned, it has major support at 35,300-35,100 zone, below which further downside into the prices can't be ruled out.

    Here are three buy calls for next 2-3 weeks

    Max Healthcare Institute: Buy | LTP: Rs 380.20 | Stop Loss: Rs 340 | Target: Rs 422 | Return: 11 percent

    After hitting its 52-week high of Rs 402.60 in September, the stock saw profit-booking at higher levels and retraced towards Rs 330 levels. The stock can be seen trading in a consolidation zone since then. In recent past, the stock took support at its 100-day exponential moving average on daily charts and formed a rounding bottom pattern to once again to reclaim a move above Rs 370 levels.

    From the technical front, prices have given a breakout above the consolidation zone after nearly eight weeks. The rising volumes along with price action suggests for next up leg into the prices. Traders can accumulate the stock in the range of Rs 370-380 for the upside target of Rs 422 with stop loss below Rs 340.

    Image130112021

    Dr Lal PathLabs: Buy | LTP: Rs 3,789.45 | Stop Loss: Rs 3,450 | Target: Rs 4,212 | Return: 11 percent

    In a recent move, the stock took support at its 200-day exponential moving average on daily charts and bounced back sharply above Rs 3,700 levels after forming a double bottom pattern. At current juncture, the stock has managed to reclaim a move above its short-term moving averages and has given breakout above its multi week highs.

    The rising volumes with rise in price suggest a long build-up into the stock which can push prices much higher from current levels. Traders can accumulate the stock in range of Rs 3,760-3,790 for the upside target of Rs 4,212 with stop loss below Rs 3,450.

    Image230112021

    Tata Consultancy Services: Buy | LTP: Rs 3,529.15 | Stop Loss: Rs 3,330 | Target: Rs 3,840 | Return: 9 percent

    The stock tested its 52-week high of Rs 3,989.90 in October and since then seen trading lower on the back of profit-booking. From the last one month, the stock can be seen trading in a broader range of Rs 3,400-3,550.

    At the current juncture, the stock has formed a double bottom pattern on the technical front and once again managed to close above its 100-day exponential moving average on daily charts.

    The sudden surge in volumes with a rise in price suggests continuation of a rally into upcoming sessions. Traders can accumulate the stock in the Rs 3,520-3,530 range for the upside target of Rs 3,840 with stop loss below Rs 3,330.

    Image330112021

    Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

    Shitij Gandhi
    Shitij Gandhi is a senior technical analyst at SMC Global Securities
    first published: Dec 1, 2021 07:25 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347